Alignment Healthcare, Inc. Stock 12‑Month Price Target Cut to $11.21, Implies 39% Upside
Alignment Healthcare's average 12-month price target was reduced to $11.21 by analysts, down from $12.31, with a range of $8 to $17. This implies a 39% upside from the Oct. 29 closing price. The consensus rating remains 'Buy' among 16 analysts.
How this was made

The 30-second read
Why it matters
Analyst consensus remains a Buy, but the lower target suggests a more modest near‑term upside.
Market read
The target cut provides a modestly new data point for traders monitoring small‑cap healthcare stocks.
What to watch
Potential pipeline developments or partnership news not reflected in the target change.
Background
Alignment Healthcare is a micro‑cap healthcare services company whose stock is closely watched by niche investors.
Ticker impact
Analysts cut the average 12-month price target for Alignment Healthcare to $11.21, implying 39% upside from the recent close.
likely downward pressure as investors reassess valuation
The new target is lower than the prior consensus, signaling weaker outlook despite a still‑positive upside estimate.
Market effects
Minor impact on the healthcare services sector as analysts adjust expectations for a small‑cap player.
Limited to U.S. small‑cap investors.
Low
Counterpoint
The target cut may be overly cautious; the stock could still rally on upcoming data.
Key entities
- CompanyAlignment Healthcare, Inc.
Subject of the price‑target revision.




